Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Dina Tiniakos.

Newcastle AuthorsTitleYearFull text
Dr Steven Masson
Dr Dina Tiniakos
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease2022
Dr Dina Tiniakos
Professor Quentin Anstee
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD2022
Dr Dina Tiniakos
Consensus Recommendations for Histological Criteria of Autoimmune Hepatitis from the International AIH Pathology Group2022
Nicola Dyson
Dr Nicole Kattner
Minna Honkanen-Scott
Bethany Hunter
Jennifer Doyle
et al.
Development and Application of a Semi quantitative Scoring Method for Ultrastructural Assessment of Acute Stress in Pancreatic Islets2022
Dr Dina Tiniakos
How to identify, encourage, and support suitable candidates for leading roles in scientific societies: The UEG experience2022
Dr Katherine Johnson
Dr Peter Leary
Dr Olivier Govaere
Dr Matthew Barter
Sarah Charlton
et al.
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance2022
Dr Olivier Govaere
Dr Rebecca Darlay
Dr Julien Peltier
Dr Jeremy Palmer
Dr Massimo Younes
et al.
Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease2022
Dr Dina Tiniakos
Specific Neuropeptide Expression in Crohn's Disease Ileocolonic Resection Specimens Is Not Associated with Plexitis at the Ileal Margin or Postoperative Recurrence2022
Dr Dina Tiniakos
“Dual aetiology fatty liver disease”: A recently proposed term associated with potential pitfalls2021
Dr Dina Tiniakos
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD2021
Dr Dina Tiniakos
Burnout in gastroenterology: raise awareness and identify drivers2021
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Zaki
et al.
Caucasian Lean Subjects with Non-Alcoholic Fatty Liver Disease Share Long-Term Prognosis of Non-Lean: Time for Reappraisal of BMI-Driven Approach?2021
Dr Massimo Younes
Rachel Burgoyne
Dr Dina Tiniakos
Dr Olivier Govaere
Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease2021
Dr Dina Tiniakos
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease2021
Dr Dina Tiniakos
Experimental Intestinal Stenosis Alters Crohn's Disease-Like Intestinal Inflammation in Ileitis-Prone Mice2021
Professor Alastair Burt
Professor Pierre Bedossa
Dr Dina Tiniakos
Fifty years of impact on liver pathology: a history of the Gnomes2021
Dr Dina Tiniakos
From the origin of NASH to the future of metabolic fatty liver disease2021
Dr Dina Tiniakos
Inflammatory myoglandular polyp as a cause of recurrent abdominal pain in a patient with quiescent Crohn's disease2021
Dr Dina Tiniakos
Keratin 7 expression in hepatic cholestatic diseases2021
Marco Zaki
Dr Ahmed Mahdi
Dr Gillian Patman
Anna Whitehead
Joao Mauricio
et al.
Key features of the environment promoting liver cancer in the absence of cirrhosis2021
Dr Dina Tiniakos
Liver stiffness measurements by 2-dimensional shear wave elastography compared to histological and ultrasound parameters in primary biliary cholangitis2021
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Youssef William Zaki
et al.
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease2021
Dr Arianna Bianchi
Letizia Marchetti
Hannah Paish
Dr Kile Green
Dr Dina Tiniakos
et al.
Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis2021
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Pierre Bedossa
Dr Simon Cockell
Dr Massimo Younes
et al.
NASH limits anti-tumor surveillance in immunotherapy-treated HCC2021
Dr Dina Tiniakos
Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path)2021
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Quentin Anstee
Professor Fiona Oakley
Bone Morphogenic Protein 8B Promotes the Progression of Non-Alcoholic Steatohepatitis2020
Dr Dina Tiniakos
Burnout among gastroenterologists: How to manage and prevent it2020
Dr Nicole Kattner
Nicola Dyson
Dr Yvonne Bury
Dr Dina Tiniakos
Tracey Davey
et al.
Development and validation of a quantitative electron microscopy score to assess acute cellular stress in the human exocrine pancreas2020
Dr Dina Tiniakos
Experimental Models of Partial Intestinal Obstruction in Young Mice: Establishment, and Evaluation2020
Professor Quentin Anstee
Dr Rebecca Darlay
Dr Simon Cockell
Dr Olivier Govaere
Dr Dina Tiniakos
et al.
Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort2020
Dr Dina Tiniakos
Innervation of the proximal human biliary tree.2020
Dr Dina Tiniakos
Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?2020
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Zaki
et al.
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease2020
Dr Massimo Younes
Dr Olivier Govaere
Dr Luca Miele
Dr Dina Tiniakos
Professor Alastair Burt
et al.
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease2020
Dr Dina Tiniakos
Susan Harrison
Professor Quentin Anstee
qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients with Non-Alcoholic Steatohepatitis2020
Dr Timothy Hardy
Kristy Wonders
Dr Massimo Younes
Professor Pierre Bedossa
Entesar Betelmal
et al.
The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease2020
Dr Olivier Govaere
Dr Simon Cockell
Dr Dina Tiniakos
Dr Rachel Queen
Dr Massimo Younes
et al.
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis2020
Dr Dina Tiniakos
Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study2019
Dr Dina Tiniakos
Bizarre stromal cells in Crohn's disease2019
Dr Dina Tiniakos
Fibrosis and alcohol-related liver disease2019
Dr Marie Boyle
Kate Hallsworth
Dr Dina Tiniakos
Professor Quentin Anstee
Health-related Quality of Life in Non-alcoholic Fatty Liver Disease Associates With Hepatic Inflammation.2019
Dr Sam Tingle
Dr Avinash Sewpaul
Steven White
Dr Dina Tiniakos
Hepatocellular neoplasm of uncertain malignant potential associated with hepatic granulomas featuring p62-positive asteroid bodies.2019
Dr Maria Perugorria
Professor Fiona Oakley
Professor Jelena Mann
Dr Dina Tiniakos
Professor Derek Mann
et al.
Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage2019
Dr Joaquim Majo
Dr Dina Tiniakos
Pathology and natural history of organ fibrosis2019
Dr Marie Boyle
Dr Dina Tiniakos
Dr Olivier Govaere
Dr Massimo Younes
Dr Stuart McPherson
et al.
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease2019
Dr Sameh Abou-Beih
Dr Steven Masson
Professor Fiona Oakley
Dr Dina Tiniakos
Sinusoidal and pericellular fibrosis in adult post-transplant liver biopsies: association with hepatic stellate cell activation and patient outcome2019
Dr Dina Tiniakos
Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report.2019
Dr Dave Houghton
Dr Kate Hallsworth
Dr Sophie Cassidy
Christian Thoma
Dr Leah Avery
et al.
The degree of hepatic steatosis associates with impaired cardiac and autonomic function2019
Dr Dina Tiniakos
Dr Diana Jurk
A novel Sudan Black B-based analogue revives lipofuscin as a biomarker for in vivo senescence2018
Dr Dina Tiniakos
Can reference images improve interobserver agreement in reporting liver fibrosis?2018
Dr Dina Tiniakos
Professor Quentin Anstee
Professor Alastair Burt
Fatty Liver Disease2018
Dr Dina Tiniakos
Joao Pais Maurício-Muir
Professor Helen Reeves
Fatty liver disease and hepatocellular carcinoma: The pathologist’s view2018
Sebastian Mafeld
Jeremy French
Dr Dina Tiniakos
Dr Beate Haugk
Professor Derek Manas
et al.
Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection2018
Dr Olivier Govaere
Dr Dina Tiniakos
Hepatic Progenitor Cells in Metastatic Liver Carcinomas2018
Dr Scott Anderson
Dr Michael White
Sarah Armour
Rashmi Maheshwari
Dr Dina Tiniakos
et al.
Loss of end-differentiated β-cell phenotype following pancreatic islet transplantation2018
Dr Jess Dyson
Dr Dina Tiniakos
Professor David Jones
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines2018
Dr Dina Tiniakos
A case of ruptured HCC in resolving NASH associated with type 2 diabetes: Is early detection of diabetes-related HCC feasible?2017
Dr Stuart McPherson
Dr Nina Wilson
Dr Dina Tiniakos
Dr Jennifer Wilkinson
Professor Alastair Burt
et al.
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis2017
Dr Stuart McPherson
Dr Timothy Hardy
Dr Dina Tiniakos
Professor Alastair Burt
Professor Chris Day
et al.
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis2017
Dr Mikolaj Ogrodnik
Dr Satomi Miwa
Dr Dina Tiniakos
Dr Caroline Wilson
Professor Chris Day
et al.
Cellular senescence drives age-dependent hepatic steatosis2017
Dr Dave Houghton
Christian Thoma
Dr Kate Hallsworth
Dr Sophie Cassidy
Dr Timothy Hardy
et al.
Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial2017
Professor Alastair Burt
Dr Dina Tiniakos
Fibrosis evaluation by transient elastography in alcoholic liver disease: Is the histological scoring system impacting cutoff values?2017
Dr Timothy Hardy
Dr Mujdat Zeybel
Professor Chris Day
Dr Christian Dipper
Dr Steven Masson
et al.
Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease2017
Dr Anna Moles Fernandez
Dr Jacqueline Butterworth
Dr Jill Hunter
Dr Jack Leslie
Helene Sellier
et al.
A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-kB dependent liver regeneration and cancer2016
Dr Dina Tiniakos
Atrophic hepatocytes express keratin 7 in ischemia-associated liver lesions2016
Dr Dina Tiniakos
Professor Quentin Anstee
Professor Chris Day
Professor Alastair Burt
Dr John Brain
et al.
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference2016
Kile Green
Dr Laura Jopson
Dr Ben Barron-Millar
Barbara Innes
Sarah Pagan
et al.
Early Molecular Stratification of High-risk Primary Biliary Cholangitis2016
Dr Sameh Abou-Beih
Dr Steven Masson
Professor Fiona Oakley
Dr Dina Tiniakos
Evaluation of centrilobular fibrosis in post-transplant liver: Preliminary results2016
Dr Dina Tiniakos
Evaluation of liver fibrosis: “Something old, something new…”2016
Dr Jess Dyson
Dr Dina Tiniakos
Dr Stuart McPherson
Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use2016
Dr Sari Alhasan
Dr Beate Haugk
Laura Ogle
Dr Gary Beale
Anna Long
et al.
Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma2016
Dr Dina Tiniakos
Alcoholic and Non-alcoholic Fatty Liver Disease2015
Dr Dina Tiniakos
Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease2015
Dr Dina Tiniakos
Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity2015
Professor Alastair Burt
Dr Dina Tiniakos
Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification2015
Anna Whitehead
Dr Gillian Patman
Professor Chris Day
Dr Dina Tiniakos
Professor Quentin Anstee
et al.
Effects of FXR agonist PX20606 on tumour formation in animal models of non-alcoholic fatty liver disease2015
Dr Dina Tiniakos
Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy.2015
Dr Dina Tiniakos
Histamine H3 and H4 Receptor Ligands Modify Vascular Histamine Levels in Normal and Arthritic Large Blood Vessels In Vivo2015
Dr Dina Tiniakos
Increased abdominal fat levels measured by bioelectrical impedance are associated with histological lesions of nonalcoholic steatohepatitis.2015
Dr Dina Tiniakos
Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma2015
Dr Dina Tiniakos
Liver innervation and hepatic function: new insights2015
Dr Caroline Wilson
Dr Diana Jurk
Nicola Fullard
Paul Banks
Dr Agata Page
et al.
NFkB1 is a suppressor of neutrophil-driven hepatocellular carcinoma2015
Dr Dina Tiniakos
Dr Yvonne Bury
p62 (SQSTM1) expression in human liver disease: Preliminary results2015
Anna Whitehead
Laura Ogle
Dr Gillian Patman
Dr Ali Anwar
Dr Dina Tiniakos
et al.
Ras and p-ERK in metabolic syndrome associated Hepatocellular Carcinoma (HCC)2015
Dr Dina Tiniakos
Dr John Brain
Dr Yvonne Bury
Role of Histopathology in Autoimmune Hepatitis2015
Dr Anna Moles Fernandez
Dr Jacqueline Butterworth
Dr Jill Hunter
Dr Dina Tiniakos
Professor Derek Mann
et al.
Thr505 RelA phosphorylation controls liver proliferative response and supresses NF-kappa B tumor-promoting activities2015
Dr Caroline Wilson
Dr Lindsay Murphy
Jack Leslie
Dr Stuart Kendrick
Jeremy French
et al.
Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease2015
Professor Alastair Burt
Dr Dina Tiniakos
Well-differentiated hepatocellular neoplasm of uncertain malignant potential - reply2015
Dr Dina Tiniakos
Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease2014
Dr Dina Tiniakos
CD138 (syndecan 1) expression in health and disease2014
Dr Dina Tiniakos
Dental Pulp cells enhance bone healing in a rat osteotomy model2014
Dr Dina Tiniakos
Estrogen receptor beta 2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions2014
Dr Dina Tiniakos
Histological features of chronic hepatitis C in haemodialysis patients2014
Dr Dina Tiniakos
Liver Function Breath Tests for Differentiation of Steatohepatitis from Simple Fatty Liver in Patients with Nonalcoholic Fatty Liver Disease2014
Dr Dina Tiniakos
Liver regeneration: immunohistochemichal study of intrinsic hepatic innervation after partial hepatectomy in rats2014
Dr Dina Tiniakos
Medial tibial stress syndrome: A skeleton from medieval Rhodes demonstrates the appearance of the bone surface2014
Dr Yvonne Bury
Naomi Brown
Dr Dina Tiniakos
p53 expression in human hepatocellular carcinoma (HCC): correlation with dysadherin expression and patient prognosis2014
Dr Dina Tiniakos
Professor Alastair Burt
Pathology of the Liver Sinusoids2014
Dr Dina Tiniakos
The impact of cereal grain consumption on the development and severity of non-alcoholic fatty liver disease2014
Dr Dina Tiniakos
Professor Alastair Burt
The liver, gallbladder and pancreas2014
Dr Yang-Lin Liu
Professor Helen Reeves
Professor Alastair Burt
Dr Dina Tiniakos
Dr Stuart McPherson
et al.
TM6SF2 rs58542926 Influences Hepatic Fibrosis Progression in Patients with Non-Alcoholic Fatty Liver Disease2014
Professor Pierre Bedossa
Professor Alastair Burt
Dr Dina Tiniakos
Dr John Brain
Dr Yvonne Bury
et al.
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease2014
Dr Dina Tiniakos
Dr John Brain
Dr Yvonne Bury
Utility and appropriateness of the FLIP algorithm and SAF score in the evaluation of biopsies of nonalcoholic fatty liver disease.2014
Professor Pierre Bedossa
Professor Alastair Burt
Dr Dina Tiniakos
Well differentiated hepatocellular neoplasm of uncertain malignant potential: Proposal for a new diagnostic category2014
Dr Dina Tiniakos
Application, Utility and Validation of a New Histological System for Classification of NAFLD in Patients with Metabolic Syndrome2013
Dr Dina Tiniakos
E2F transcription factors and digestive system malignancies: How much do we know?2013
Dr Dina Tiniakos
Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma2013
Dr Dina Tiniakos
Increased Density of Cutaneous Nerve Fibres in the Affected Dermatomes After Herpes Zoster Therapy2013
Dr Dina Tiniakos
The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease2013
Dr Dina Tiniakos
E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma2012
Dr Dina Tiniakos
Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis2012
Dr Dina Tiniakos
Treatment With Simvastatin Inhibits the Formation of Abdominal Aortic Aneurysms in Rabbits2012
Dr Dina Tiniakos
Effect of Antiviral Therapy on the Immunohistochemical Expression of bcl-xL and Bax Protein in Patients With HBeAg-Negative Chronic Hepatitis B2011
Dr Dina Tiniakos
Exercise for NAFLD: Does Intensity Matter?2011
Dr Dina Tiniakos
Fighting the bushfire in HCC trials2011
Dr Dina Tiniakos
Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B2011
Dr Dina Tiniakos
IGF-I ameliorates hippocampal neurodegeneration and protects against cognitive deficits in an animal model of temporal lobe epilepsy2011
Dr Dina Tiniakos
Inflammation in nonalcoholic steatohepatitis2011
Dr Dina Tiniakos
Insights into ectopic estrogen receptor expression, nucleocytoplasmic distribution and interaction with chromatin obtained with new antibodies to estrogen receptors α and β2011
Dr Dina Tiniakos
Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patients2011
Dr Dina Tiniakos
Serum leptin and ghrelin in chronic hepatitis C patients with steatosis2011
Dr Dina Tiniakos
Dysadherin expression in human hepatocellular carcinoma: preliminary results2010
Dr Dina Tiniakos
Histopathology of nonalcoholic fatty liver disease2010
Dr Dina Tiniakos
Primary Hepatic Actinomycosis2010
Dr Dina Tiniakos
Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease2009
Dr Dina Tiniakos
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program2008
Dr Dina Tiniakos
Professor Alastair Burt
Ontogeny of human intrahepatic innervation2008
Dr Dina Tiniakos
Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection2008
Dr Dina Tiniakos
Dr John Anderson
c-fos oncogene expression in human breast carcinoma2000
Dr Dina Tiniakos
Dr John Anderson
Production and characterization of monoclonal antibodies to the human c-fos oncoprotein effective an routinely-processed tissues2000
Dr Dina Tiniakos
Dr John Anderson
Dr Mary Robinson
Professor David Neal
c-jun oncogene expression in transitional cell carcinoma of the urinary bladder1994